The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM
Open accessAbstract
Activation of the p53 tumor suppressor can lead to cell cycle arrest. The key mechanism of p53-mediated arrest is transcriptional downregulation of many cell cycle genes. In recent years it has become evident that p53-dependent repression is controlled by the p53–p21–DREAM–E2F/CHR pathway (p53–DREAM pathway). DREAM is a transcriptional repressor that binds to E2F or CHR promoter sites. Gene regulation and deregulation by DREAM shares many mechanistic characteristics with the retinoblastoma pRB tumor suppressor that acts through E2F elements. However, because of its binding to E2F and CHR elements, DREAM regulates a larger set of target genes leading to regulatory functions distinct from pRB/E2F. The p53–DREAM pathway controls more than 250 mostly cell cycle-associated genes. The functional spectrum of these pathway targets spans from the G 1 phase to the end of mitosis. Consequently, through downregulating the expression of gene products which are essential for progression through the cell cycle, the p53–DREAM pathway participates in the control of all checkpoints from DNA synthesis to cytokinesis including G 1 /S, G 2 /M and spindle assembly checkpoints. Therefore, defects in the p53–DREAM pathway contribute to a general loss of checkpoint control. Furthermore, deregulation of DREAM target genes promotes chromosomal instability and aneuploidy of cancer cells. Also, DREAM regulation is abrogated by the human papilloma virus HPV E7 protein linking the p53–DREAM pathway to carcinogenesis by HPV. Another feature of the pathway is that it downregulates many genes involved in DNA repair and telomere maintenance as well as Fanconi anemia. Importantly, when DREAM function is lost, CDK inhibitor drugs employed in cancer treatment such as Palbociclib, Abemaciclib and Ribociclib can compensate for defects in early steps in the pathway upstream from cyclin/CDK complexes. In summary, the p53–p21–DREAM–E2F/CHR pathway controls a plethora of cell cycle genes, can contribute to cell cycle arrest and is a target for cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p53 transcriptionally regulates PCNA and 14-3-3d expression to suppress DNA replication and induce G2/M phase arrest, respectively.58,59”
From p53: from understanding its structure to advances in therapeutic targeting (2026) · cites this paper as [58]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Stöckl, S., Göttl, C., Grifka, J., & Grässel, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350089 · Cited by 4,656
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
Blinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
The human papilloma virus-16 E7-oncoprotein is able to bind to the retinoblastoma gene product
Dyson, N., Howley, P. M., Münger, K., & Harlow, E. (1989) · Science · doi:10.1126/science.2537532 · Cited by 3,017
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803
p21 in cancer: Intricate networks and multiple activities
Abbas, T., & Dutta, A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2657 · Cited by 2,712
The spindle-assembly checkpoint in space and time
Musacchio, A., & Salmon, E. D. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2163 · Cited by 2,227
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
Definition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
The first 30 years of p53: growing ever more complex.
Levine, A. J., & Oren, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2723 · Cited by 1,967
Regulation of the G2/M transition by p53
Taylor, W. R., & Stark, G. R. (2001) · Oncogene · doi:10.1038/sj.onc.1204252 · Cited by 1,559
Dulić, V., Kaufmann, W. K., Wilson, S. J., Tisty, T. D., Lees, E., Harper, J. W., Elledge, S. J., & Reed, S. I. (1994) · Cell · doi:10.1016/0092-8674(94)90379-4 · Cited by 1,465
Carter, S. L., Eklund, A. C., Kohane, I. S., Harris, L. N., & Szallasi, Z. (2006) · Nature Genetics · doi:10.1038/ng1861 · Cited by 1,193
Cheng, M., Olivier, P., Diehl, J. A., Fero, M., Roussel, M. F., Roberts, J. M., & Sherr, C. J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1571 · Cited by 1,142 · cited 1×
“inhibitors functioning as cyclin/CDK assembly factors, mediating nuclear localization of D-type cyclins, and contributing to stability of cyclin D-CDK4 complexes.(58,63,64) Thus, it remains open whether additional signaling steps aside from the p53– p21/CDKN1A axis signal into the DREAM pathway.”
BackgroundTreating cancer with selective CDK4/6 inhibitors
O'Leary, B., Finn, R. S., & Turner, N. C. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.26 · Cited by 1,137
Inhibition of cyclin-dependent kinases by p21.
Harper, J. W., Elledge, S. J., Keyomarsi, K., Dynlacht, B., Tsai, L. H., Zhang, P., Dobrowolski, S., Bai, C., Connell-Crowley, L., & Swindell, E. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.4.387 · Cited by 1,023
Census and evaluation of p53 target genes
Fischer, M. (2017) · Oncogene · doi:10.1038/onc.2016.502 · Cited by 971
Regulation of the specific DNA binding function of p53
Hupp, T. R., Meek, D. W., Midgley, C. A., & Lane, D. P. (1992) · Cell · doi:10.1016/0092-8674(92)90562-q · Cited by 909
Mitotic catastrophe: a mechanism for avoiding genomic instability
Vitale, I., Galluzzi, L., Castedo, M., & Kroemer, G. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3115 · Cited by 834
Abnormal Centrosome Amplification in the Absence of p53
Fukasawa, K., Choi, T., Kuriyama, R., Rulong, S., & Woude, G. F. V. (1996) · Science · doi:10.1126/science.271.5256.1744 · Cited by 797
The Fanconi anaemia pathway: new players and new functions
Ceccaldi, R., Sarangi, P., & D'Andrea, A. D. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.48 · Cited by 720
Targeted disruption of the three Rb-related genes leads to loss of G 1 control and immortalization
Sage, J., Mulligan, G. J., Attardi, L. D., Miller, A., Chen, S., Williams, B., Theodorou, E., & Jacks, T. (2000) · Genes & Development · doi:10.1101/gad.843200 · Cited by 582
The DREAM complex: master coordinator of cell cycle-dependent gene expression
Sadasivam, S., & DeCaprio, J. A. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3556 · Cited by 524
Proliferation of aneuploid human cells is limited by a p53-dependent mechanism
Thompson, S. L., & Compton, D. A. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200905057 · Cited by 494
Conserved functions of the pRB and E2F families
van den Heuvel, S., & Dyson, N. J. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2469 · Cited by 494
Chibon, F., Lagarde, P., Salas, S., Pérot, G., Brouste, V., Tirode, F., Lucchesi, C., de Reynies, A., Kauffmann, A., Bui, B., et al. (2010) · Nature Medicine · doi:10.1038/nm.2174 · Cited by 474
Pathways governing G1/S transition and their response to DNA damage
Bartek, J., & Lukas, J. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02114-7 · Cited by 471
p53 regulates a G 2 checkpoint through cyclin B1
Innocente, S. A., Abrahamson, J. L. A., Cogswell, J. P., & Lee, J. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2147 · Cited by 436
RB1: a prototype tumor suppressor and an enigma
Dyson, N. J. (2016) · Genes & Development · doi:10.1101/gad.282145.116 · Cited by 435
Litovchick, L., Sadasivam, S., Florens, L., Zhu, X., Swanson, S. K., Velmurugan, S., Chen, R., Washburn, M. P., Liu, X. S., & DeCaprio, J. A. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.04.015 · Cited by 396
A p53-Dependent Checkpoint Pathway Prevents Rereplication
Vaziri, C., Saxena, S., Jeon, Y., Lee, C., Murata, K., Machida, Y., Wagle, N., Hwang, D. S., & Dutta, A. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00099-6 · Cited by 393
Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins
Rozenblatt-Rosen, O., Deo, R. C., Padi, M., Adelmant, G., Calderwood, M. A., Rolland, T., Grace, M., Dricot, A., Askenazi, M., Tavares, M., et al. (2012) · Nature · doi:10.1038/nature11288 · Cited by 378
Centrosome Amplification Is Sufficient to Promote Spontaneous Tumorigenesis in Mammals
Levine, M. S., Bakker, B., Boeckx, B., Moyett, J., Lu, J., Vitre, B., Spierings, D. C., Lansdorp, P. M., Cleveland, D. W., Lambrechts, D., et al. (2017) · Developmental Cell · doi:10.1016/j.devcel.2016.12.022 · Cited by 376
Absence of WAF1 mutations in a variety of human malignancies
Shiohara, M., el-Deiry, W., Wada, M., Nakamaki, T., Takeuchi, S., Yang, R., Chen, D., Vogelstein, B., & Koeffler, H. (1994) · Blood · doi:10.1182/blood.v84.11.3781.bloodjournal84113781 · Cited by 368
Hypoxia-Induced Down-regulation of BRCA1 Expression by E2Fs
Bindra, R. S., Gibson, S. L., Meng, A., Westermark, U., Jasin, M., Pierce, A. J., Bristow, R. G., Classon, M. K., & Glazer, P. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2119 · Cited by 334
Fischer, M., Grossmann, P., Padi, M., & DeCaprio, J. A. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw523 · Cited by 330
Musa, J., Aynaud, M.-M., Mirabeau, O., Delattre, O., & Grünewald, T. G. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.244 · Cited by 322
The p53-p21-DREAM-CDE/CHR pathway regulates G2/M cell cycle genes
Fischer, M., Quaas, M., Steiner, L., & Engeland, K. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv927 · Cited by 321
Self-citationThe MuvB complex sequentially recruits B-Myb and FoxM1 to promote mitotic gene expression
Sadasivam, S., Duan, S., & DeCaprio, J. A. (2012) · Genes & Development · doi:10.1101/gad.181933.111 · Cited by 309
Blake, M. C., & Azizkhan, J. C. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.11.4994-5002.1989 · Cited by 287
Cdc6 is regulated by E2F and is essential for DNA replication in mammalian cells
Yan, Z., DeGregori, J., Shohet, R., Leone, G., Stillman, B., Nevins, J. R., & Williams, R. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3603 · Cited by 266
Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes.
Beijersbergen, R. L., Carlée, L., Kerkhoven, R. M., & Bernards, R. (1995) · Genes & Development · doi:10.1101/gad.9.11.1340 · Cited by 248
Chen, X., Müller, G. A., Quaas, M., Fischer, M., Han, N., Stutchbury, B., Sharrocks, A. D., & Engeland, K. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00881-12 · Cited by 226
Self-citationp63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53
Melino, G. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2011.81 · Cited by 224
The PIDDosome activates p53 in response to supernumerary centrosomes
Fava, L. L., Schuler, F., Sladky, V., Haschka, M. D., Soratroi, C., Eiterer, L., Demetz, E., Weiss, G., Geley, S., Nigg, E. A., et al. (2017) · Genes & Development · doi:10.1101/gad.289728.116 · Cited by 215
Biological functions of p53 isoforms through evolution: lessons from animal and cellular models
Marcel, V, Dichtel-Danjoy, M.-L., Sagne, C., Hafsi, H., Ma, D., Ortiz-Cuaran, S., Olivier, M., Hall, J., Mollereau, B., Hainaut, P., et al. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2011.120 · Cited by 210
Interplay between Fanconi anemia and homologous recombination pathways in genome integrity
Michl, J., Zimmer, J., & Tarsounas, M. (2016) · The EMBO Journal · doi:10.15252/embj.201693860 · Cited by 204
Mechanisms of G2 Arrest in Response to Overexpression of p53
Taylor, W. R., DePrimo, S. E., Agarwal, A., Agarwal, M. L., Schönthal, A. H., Katula, K. S., & Stark, G. R. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.11.3607 · Cited by 195
p53-Dependent cell cycle control: response to genotoxic stress
Schwartz, D., & Rotter, V. (1998) · Seminars in Cancer Biology · doi:10.1006/scbi.1998.0095 · Cited by 195
DNA replication origins—where do we begin?
Prioleau, M.-N., & MacAlpine, D. M. (2016) · Genes & Development · doi:10.1101/gad.285114.116 · Cited by 195
Prime movers: the mechanochemistry of mitotic kinesins
Cross, R. A., & McAinsh, A. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3768 · Cited by 190
Schmit, F., Korenjak, M., Mannefeld, M., Schmitt, K., Franke, C., von Eyss, B., Gagrica, S., Hanel, F., Brehm, A., & Gaubatz, S. (2007) · Cell Cycle · doi:10.4161/cc.6.15.4512 · Cited by 179
Telomeropathies: An emerging spectrum disorder
Holohan, B., Wright, W. E., & Shay, J. W. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201401012 · Cited by 175
p53 Down-Regulates CHK1 through p21 and the Retinoblastoma Protein
Gottifredi, V., Karni-Schmidt, O., Shieh, S.-Y., & Prives, C. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.4.1066-1076.2001 · Cited by 172
The NF-κB Genomic Landscape in Lymphoblastoid B Cells
Zhao, B., Barrera, L. A., Ersing, I., Willox, B., Schmidt, S. C. S., Greenfeld, H., Zhou, H., Mollo, S. B., Shi, T. T., Takasaki, K., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.037 · Cited by 171
The tumour suppressor protein p53 can repress transcription of cyclin B
Krause, K. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.22.4410 · Cited by 171
Transcriptional repression mediated by the p53 tumour suppressor
Ho, J., & Benchimol, S. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401191 · Cited by 166
p21 Is a Critical CDK2 Regulator Essential for Proliferation Control in Rb-deficient Cells
Brugarolas, J., Bronson, R. T., & Jacks, T. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.2.503 · Cited by 153
The transcription factor p53: Not a repressor, solely an activator.
Fischer, M., Steiner, L., & Engeland, K. (2014) · Cell Cycle · doi:10.4161/15384101.2014.949083 · Cited by 153
Self-citationHow theTP53Family ProteinsTP63andTP73Contribute to Tumorigenesis: Regulators and Effectors
Candi, E., Agostini, M., Melino, G., & Bernassola, F. (2014) · Human Mutation · doi:10.1002/humu.22523 · Cited by 152
p73 Is Required for Multiciliogenesis and Regulates the Foxj1-Associated Gene Network
Marshall, C. B., Mays, D. J., Beeler, J. S., Rosenbluth, J. M., Boyd, K. L., Guasch, G. L. S., Shaver, T. M., Tang, L. J., Liu, Q., Shyr, Y., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.035 · Cited by 151
Living in CIN: Mitotic Infidelity and Its Consequences for Tumor Promotion and Suppression
Hrycyniak, L., Zasadil, L. M., & Weaver, B. A. A. (2016) · Developmental Cell · doi:10.1016/j.devcel.2016.10.023 · Cited by 148
Requirements for Cell Cycle Arrest by p16INK4a
Bruce, J. L., Hurford, R. K., Classon, M., Koh, J., & Dyson, N. J. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00072-1 · Cited by 146
Blake, M. C., & Azizkhan, J. C. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.11.4994 · Cited by 145
Müller, G. A., & Engeland, K. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07508.x · Cited by 130
Self-citationOsterloh, L., von Eyß, B., Schmit, F., Rein, L., Hübner, D., Samans, B., Hauser, S., & Gaubatz, S. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601478 · Cited by 124
Müller, G. A., Quaas, M., Schümann, M., Krause, E., Padi, M., Fischer, M., Litovchick, L., DeCaprio, J. A., & Engeland, K. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr793 · Cited by 121
Self-citationPellacani, D., Bilenky, M., Kannan, N., Heravi‐Moussavi, A., Knapp, D. J. H. F., Gakkhar, S., Moksa, M., Carles, A., Moore, R. A., Mungall, A. J. J., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.10.058 · Cited by 120
Human papilloma virus E7 oncoprotein abrogates the p53-p21-DREAM pathway
Fischer, M., Uxa, S., Stanko, C., Magin, T. M., & Engeland, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-02831-9 · Cited by 119
Self-citationSpurgers, K. B., Gold, D. L., Coombes, K. R., Bohnenstiehl, N. L., Mullins, B., Meyn, R. E., Logothetis, C. J., & McDonnell, T. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513901200 · Cited by 114
Chromatin dynamics during the cell cycle at centromeres
Müller, S., & Almouzni, G. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2016.157 · Cited by 111
p130/E2F4 Binds to and Represses the cdc2 Promoter in Response to p53
Taylor, W. R., Schönthal, A. H., Galante, J., & Stark, G. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005101200 · Cited by 110
Rao, C. V., Yamada, H. Y., Yao, Y., & Dai, W. H. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp081 · Cited by 110
Quaas, M., Müller, G. A., & Engeland, K. (2012) · Cell Cycle · doi:10.4161/cc.22917 · Cited by 107
Self-citationSchmit, F., Cremer, S., & Gaubatz, S. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07261.x · Cited by 106
RHAMM is differentially expressed in the cell cycle and downregulated by the tumor suppressor p53
Sohr, S., & Engeland, K. (2008) · Cell Cycle · doi:10.4161/cc.7.21.7014 · Cited by 104
Self-citationBiomolecular Events in Cancer Revealed by Attractor Metagenes
Cheng, W., Yang, T.-H. O., & Anastassiou, D. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002920 · Cited by 104
The CHR site: definition and genome-wide identification of a cell cycle transcriptional element
Müller, G. A., Wintsche, A., Stangner, K., Prohaska, S. J., Stadler, P. F., & Engeland, K. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku696 · Cited by 103
Self-citationG1/S-regulated E2F-containing protein complexes bind to the mouse thymidine kinase gene promoter.
Dou, Q. P., Zhao, S., Levin, A., Wang, J., Helin, K., & Pardee, A. B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42259-9 · Cited by 99
Jackson, M. W., Agarwal, M. K., Yang, J., Bruss, P., Uchiumi, T., Agarwal, M. L., Stark, G. R., & Taylor (2005) · Journal of Cell Science · doi:10.1242/jcs.02307 · Cited by 92
Regulating telomere length from the inside out: the replication fork modelPreprint
Greider, C. W. (2016) · Genes & Development · doi:10.1101/gad.280578.116 · Cited by 91
Binding of FoxM1 to G2/M gene promoters is dependent upon B-Myb
Down, C. F., Millour, J., Lam, E. W. ‐., & Watson, R. J. (2012) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2012.03.008 · Cited by 90
Centrosome dynamics as a source of chromosomal instability
Nam, H.-J., Naylor, R. M., & van Deursen, J. M. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.10.002 · Cited by 83
B-MYB Is Required for Recovery from the DNA Damage–Induced G2 Checkpoint in p53 Mutant Cells
Mannefeld, M., Klassen, E., & Gaubatz, S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4156 · Cited by 82
Essential role for centromeric factors following p53 loss and oncogenic transformationPreprint
Filipescu, D., Naughtin, M., Podsypanina, K., Lejour, V., Wilson, L., Gurard‐Levin, Z. A., Orsi, G. A., Simeonova, I., Toufektchan, E., Attardi, L. D., et al. (2017) · Genes & Development · doi:10.1101/gad.290924.116 · Cited by 81
SWIM: a computational tool to unveiling crucial nodes in complex biological networks
Paci, P., Colombo, T., Fiscon, G., Gurtner, A., Pavesi, G., & Farina, L. (2017) · Scientific Reports · doi:10.1038/srep44797 · Cited by 76
Toledo, S. D., Azzam, E. I., Keng, P. C., Laffrenier, S., & Little, J. B. (1998) · PubMed · Cited by 74
Distinct Phosphorylation Events Regulate p130- and p107-mediated Repression of E2F-4
Farkas, T., Hansen, K. H., Holm, K., Lukas, J., & Bártek, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200381200 · Cited by 73
TRAIP is a PCNA-binding ubiquitin ligase that protects genome stability after replication stress
Hoffmann, S., Smedegaard, S. B., Nakamura, K., Mortuza, G. B., Räschle, M., de Opakua, A. I., Oka, Y., Feng, Y., Blanco, F. J., Mann, M., et al. (2015) · The Journal of Cell Biology · doi:10.1083/jcb.201506071 · Cited by 73
FOXM1 binds directly to non-consensus sequences in the human genome
Sanders, D. A., Gormally, M. V., Marsico, G., Beraldi, D., Tannahill, D., & Balasubramanian, S. (2015) · Genome biology · doi:10.1186/s13059-015-0696-z · Cited by 70
Structural basis for LIN54 recognition of CHR elements in cell cycle-regulated promoters
Marceau, A. H., Felthousen, J. G., Goetsch, P. D., Iness, A. N., Lee, H., Tripathi, S. M., Strome, S., Litovchick, L., & Rubin, S. M. (2016) · Nature Communications · doi:10.1038/ncomms12301 · Cited by 68
Tovy, A., Spiro, A., McCarthy, R. L., Shipony, Z., Aylon, Y., Allton, K. L., Ainbinder, E., Furth, N., Tanay, A., Barton, M. C., et al. (2017) · Genes & Development · doi:10.1101/gad.299198.117 · Cited by 68
Fischer, M., Quaas, M., Wintsche, A., Müller, G. A., & Engeland, K. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt849 · Cited by 66
Self-citationFischer, M., Grundke, I., Sohr, S., Quaas, M., Hoffmann, S., Knörck, A., Gumhold, C., & Rother, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063187 · Cited by 65
p53 downregulates expression of the G1/S cell cycle phosphatase Cdc25A
Rother, K., Kirschner, R., Sänger, K., Böhlig, L., Mössner, J., & Engeland, K. (2006) · Oncogene · doi:10.1038/sj.onc.1209989 · Cited by 63
Self-citationp53 downregulates the Fanconi anaemia DNA repair pathway
Jaber, S., Toufektchan, E., Lejour, V., Bardot, B., & Toledo, F. (2016) · Nature Communications · doi:10.1038/ncomms11091 · Cited by 61
Wasner, M., Tschöp, K., Spiesbach, K., Haugwitz, U., Johne, C., Mössner, J., Mantovani, R., & Engeland, K. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00028-0 · Cited by 61
Self-citationFischer, M., Quaas, M., Nickel, A., & Engeland, K. (2015) · Oncotarget · doi:10.18632/oncotarget.6356 · Cited by 61
Self-citationDietz, S., Rother, K., Bamberger, C., Schmale, H., Mössner, J., & Engeland, K. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03093-4 · Cited by 60
Self-citationOne Function—Multiple Mechanisms: The Manifold Activities of p53 as a Transcriptional Repressor
Böhlig, L., & Rother, K. (2011) · BioMed Research International · doi:10.1155/2011/464916 · Cited by 58
Li, C., Lin, M., & Liu, J. (2004) · Oncogene · doi:10.1038/sj.onc.1208114 · Cited by 58
An important role for Myb-MuvB and its target gene KIF23 in a mouse model of lung adenocarcinoma
Iltzsche, F., Simon, K., Stopp, S., Pattschull, G., Francke, S., Wolter, P., Hauser, S., Murphy, D. J., García, P., Rosenwald, A., et al. (2016) · Oncogene · doi:10.1038/onc.2016.181 · Cited by 57
Rashid, N. N., Yusof, R., & Watson, R. J. (2011) · Journal of General Virology · doi:10.1099/vir.0.035352-0 · Cited by 55
Krause, K., Haugwitz, U., Wasner, M., Wiedmann, M. W., Mössner, J., & Engeland, K. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5040 · Cited by 53
Self-citationCerqueira, A., Martín, A., Symonds, C. E., Odajima, J., Dubus, P. R., Barbacid, M., & Santamaría, D. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01163-13 · Cited by 50
Wolter, P., Hanselmann, S., Pattschull, G., Schruf, E., & Gaubatz, S. (2017) · Oncotarget · doi:10.18632/oncotarget.14466 · Cited by 49
Haugwitz, U. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.9.1967 · Cited by 48
Müller, G. A., Stangner, K., Schmitt, T., Wintsche, A., & Engeland, K. (2017) · Oncotarget · doi:10.18632/oncotarget.10888 · Cited by 48
Self-citationWolter, P., Schmitt, K., Fackler, M., Kremling, H., Probst, L., Hauser, S., Gruß, O. J., & Gaubatz, S. (2012) · Journal of Cell Science · doi:10.1242/jcs.097253 · Cited by 46
The dominant-negative interplay between p53, p63 and p73: A family affair
Billant, O., Léon, A., Guellec, S. L., Friocourt, G., Blondel, M., & Voisset, C. (2016) · Oncotarget · doi:10.18632/oncotarget.11774 · Cited by 46
Valenti, F., Ganci, F., Fontemaggi, G., Sacconi, A., Strano, S., Blandino, G., & Agostino, S. D. (2015) · Oncotarget · doi:10.18632/oncotarget.2587 · Cited by 45
Yang, A., Zhu, Z., Kettenbach, A. N., Kapranov, P., McKeon, F., Gingeras, T., & Struhl, K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011572 · Cited by 40
Valente, L. J., Aubrey, B. J., Herold, M. J., Kelly, G. L., Happo, L., Scott, C. L., Newbold, A., Johnstone, R. W., Huang, D. C. S., Vassilev, L. T., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.01.059 · Cited by 40
Transcriptional Control of Mitosis: Deregulation and Cancer
Nath, S., Ghatak, D., Das, P. K., & Roychoudhury, S. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00060 · Cited by 39
Valente, L. J., Grabow, S., Vandenberg, C. J., Strasser, A., & Janic, A. (2016) · Oncogene · doi:10.1038/onc.2015.457 · Cited by 37
Rother, K., Dengl, M., Lorenz, J., Tschöp, K., Kirschner, R. D., Mössner, J., & Engeland, K. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.02.028 · Cited by 31
Self-citationRother, K., Li, Y., Tschöp, K., Kirschner, R. D., Müller, G. A., Mössner, J., & Engeland, K. (2007) · Cell Cycle · doi:10.4161/cc.6.7.4017 · Cited by 28
Self-citationZhou, Y., Zhang, Q., Gao, G., Zhang, X., Liu, Y., Yuan, S., Wang, X., & Chen, J. J. (2016) · Journal of Virology · doi:10.1128/jvi.00513-16 · Cited by 23
Agarwal, M. K., Amin, A. R. M. R., & Agarwal, M. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2835 · Cited by 19
Cited by
Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype
Kumari, R., & Jat, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.645593 · Cited by 1,622
The multiple mechanisms that regulate p53 activity and cell fate
Hafner, A., Bulyk, M. L., Jambhekar, A., & Lahav, G. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0110-x · Cited by 1,129
Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas
Donehower, L. A., Soussi, T., Korkut, A., Liu, Y., Schultz, A., Cardenas, M., Li, X., Babur, O., Hsu, T.-K., Lichtarge, O., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.001 · Cited by 710
Chronic and Acute Toxicities of Aflatoxins: Mechanisms of Action
Benkerroum, N. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17020423 · Cited by 554
Apoptotic cell death in disease—Current understanding of the NCCD 2023
Vitale, I., Pietrocola, F., Guilbaud, E., Aaronson, S. A., Abrams, J. M., Adam, D., Agostini, M., Agostinis, P., Alnemri, E. S., Altucci, L., et al. (2023) · Cell Death & Differentiation · doi:10.1038/s41418-023-01153-w · Cited by 361
Self-citation
Metadata
- Authors
- Engeland, K.
- Venue
- Cell Death & Differentiation
- Published
- 2017-11-10
- Volume
- 25
- Issue
- 1
- Pages
- 114-132
- ISSN
- 1350-9047 (ISSN-L)
- 1476-5403
- OpenAlex
- W2767972229
- Cited by
- 656
- References
- 123
- FWCI
- 19.93
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.